Long-term survival benefit from third-line treatment for advanced colon cancer: a case report

Fruquintinib combined with sintilimab immunotherapy may represent a promising third-line treatment option for patients with pMMR mCRC.

Authors

Ye Kuang (ORCID: https://orcid.org/0000-0003-4946-3447)
Sha-dong Min
Qun Chen (ORCID: https://orcid.org/0000-0001-8638-2908)
Yiwen Wu (ORCID: https://orcid.org/0000-0001-6059-7054)
Su Ju

Institutions

Jishou University (CN)

Publication Details

Journal: Frontiers in Immunology
Published: 2025-09-12
DOI: https://doi.org/10.3389/fimmu.2025.1639287
Primary Topic: Colorectal Cancer Treatments and Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Long-term survival benefit from third-line treatment for advanced colon cancer: a case report

Ye Kuang, Sha-dong Min, Qun Chen, Yiwen Wu et al.

Sep 12, 2025

Frontiers in Immunology

Colorectal Cancer Treatments and Studies

article

Long-term survival benefit from third-line treatment for advanced colon cancer: a case report

Ye Kuang, Sha-dong Min, Qun Chen, Yiwen Wu, Su Ju

September 12, 2025article en

Abstract

Fruquintinib combined with sintilimab immunotherapy may represent a promising third-line treatment option for patients with pMMR mCRC.

Frontiers in ImmunologyVol. 16

Jishou University (CN)

Openalex Percentile: Top 66%

Colorectal Cancer Treatments and Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Long-term survival benefit from third-line treatment for advanced colon cancer: a case report — Ye Kuang, Sha-dong Min, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS